Work With Us
We are building a world-class team of professionals who are motivated by the opportunity to make a significant contribution to the health and well-being of others.
PIONEERING NEW TECHNOLOGIES
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
COMPANY NEWS
NeuroVista Raises $33.8 Million in Series B Financing, Company Changes Name from BioNeuronics
NeuroVista Corporation Receives Gold Electrode Award for “Most Promising Start-up Company”
NeuroVista Hires Mary K. Moore as Vice President of Regulatory Affairs
NeuroVista Hires Hugh H. Matsubayashi as Vice President of Intellectual Property